Compare EBS & AIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EBS | AIV |
|---|---|---|
| Founded | 1998 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 312.8M | 374.7M |
| IPO Year | 2006 | 1996 |
| Metric | EBS | AIV |
|---|---|---|
| Price | $6.49 | $2.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $12.00 | $10.00 |
| AVG Volume (30 Days) | ★ 1.6M | 944.4K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 87.41% |
| EPS Growth | 125.83 | ★ 616.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $742,900,000.00 | $138,486,000.00 |
| Revenue This Year | $1.29 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.36 | $2.49 |
| 52 Week High | $14.06 | $8.03 |
| Indicator | EBS | AIV |
|---|---|---|
| Relative Strength Index (RSI) | 60.77 | 42.21 |
| Support Level | $4.36 | $2.49 |
| Resistance Level | $8.59 | $2.74 |
| Average True Range (ATR) | 0.27 | 0.04 |
| MACD | 0.26 | 0.01 |
| Stochastic Oscillator | 97.70 | 53.12 |
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
Apartment Investment & Management Co is a self-managed real estate investment trust. It is focused on property development, redevelopment, and various other value-creating investment strategies, targeting the U.S multifamily market. Its operating segments are Development. Operating, and Other. The development segment consists of properties that are under construction or have not achieved stabilization, as well as land held for development. The operating segment includes residential apartments, communities with apartment homes that have achieved a stabilized level of operations. The other segment includes The Benson Hotel, the company's only hotel. The majority of revenue is gained from the Operating Segment.